An orchestrated balance of pro-and antiinflammatory cytokine release is critical for an innate immune response sufficient for pathogen defense without excessive detriment to host tissues. By using an unbiased forward genetic approach, we previously reported that IL-1R-associated kinase 1 binding protein 1 (IRAK1BP1) down-modulates Toll-like receptor-mediated transcription of several proinflammatory cytokines. To gain insights into the physiological relevance of the inhibitory role of IRAK1BP1 in inflammation, we generated mutant mice lacking IRAK1BP1. Here we report that IRAK1BP1 does not inhibit signaling pathways generally but rather changes the transcriptional profile of activated cells, leading to an increase in IL-10 production and promoting LPS tolerance. This shift in cytokine transcription correlates with an increased ratio of functional NF-κB subunit dimers comprised of p50/p50 homodimers relative to p50/p65 heterodimers. The increase in nuclear p50/p50 was consistent with the ability of IRAK1BP1 to bind to the p50 precursor molecule and IκB family member p105. We conclude that IRAK1BP1 functions through its effects on NF-κB as a molecular switch to bias innate immune pathways toward the resolution of inflammation.inhibitor | innate immunity | p105 | Toll-like receptor | tolerance A n effective host defense against fulminant pathogen dissemination and subsequent disease relies not only on the ability of the innate immune system to mount a robust and complete acute inflammatory response but also on control of these responses to avoid tissue injury and chronic inflammation (1-3). Thus, the necessary role of inflammation in resolution or containment of infections must be balanced carefully against its potent ability to induce immune-mediated disease.Most of our knowledge of the molecular components regulating acute inflammation has arisen from studies of the Toll-like receptor (TLR), IL-1 receptor (IL-1R), and TNF receptor (TNFR) pathways. It is clear from these studies that the innate immune response is controlled at multiple levels within the cell, from receptor proximal events, such as the binding of adaptor proteins and activation of upstream kinases, to posttranslational events, such as processing and release of effector proteins (4). Furthermore, various cytokines and chemokines can exert antagonistic effects on target cells (5). For example, IL-1R antagonist has been shown to inhibit directly the receptor interaction of IL-1 and IL-1R (6, 7). The potent antiinflammatory molecule IL-10 exerts numerous effects, including the feedback inhibition of TLR-stimulated cytokine production in macrophages as well as the expansion of T-regulatory cells (8). As such, activated cells of the innate immune system can dictate the course of an inflammatory response through the levels of pro-and antiinflammatory cytokines they secrete.The unique transcriptional responsiveness of individual genes is one mechanism by which the activation of common upstream pathways results in temporally coordinated and signal-specific c...